Executive Vice President and CEO, American Association of Colleges of Pharmacy, Arlington, Virginia.
Am J Pharm Educ. 2020 Jun;84(6):ajpe8155. doi: 10.5688/ajpe8155.
The COVID-19 pandemic is having a profound impact across the United States and the rest of the world. Health care professionals, including pharmacists, are working on the frontlines and across the spectrum of public health and research. To fully optimize the contribution of pharmacists during this crisis, state and federal policies and regulations that limit pharmacists' roles had to be identified and modified. A strong coalition of national pharmacy organizations, including the American Association of Colleges of Pharmacy, embarked upon an unprecedented level of collaboration to produce a joint statement identifying key policy recommendations. This collective continued working together as the full force of the pandemic was realized and engaged with policy makers at the state and national levels to advocate for these policy recommendations. Ideally the lessons learned in terms of the power of working together in a crisis will reframe future collaborations to the benefit of the profession and ultimately to the patients we serve.
新冠疫情正在对美国和世界其他地区产生深远影响。医疗保健专业人员，包括药剂师，正在前线和公共卫生及研究的各个领域工作。为了在这场危机中充分发挥药剂师的作用，必须确定并修改限制药剂师角色的州和联邦政策法规。包括美国药学院协会在内的全国性药学组织组成了一个强大的联盟，开展了前所未有的合作，共同发表了一份联合声明，提出了一些关键的政策建议。随着疫情的全面爆发，这个集体继续合作，并与州和国家层面的政策制定者合作，倡导这些政策建议。理想情况下，在危机中共同努力所获得的经验教训将重新构建未来的合作，使整个行业受益，最终使我们服务的患者受益。
